High Frequency and Intensity of Drinking may Attenuate Increased Inflammatory Cytokine Levels of Major Depression in Alcohol-use Disorders

CNS Neuroscience and Therapeutics

Volumn 20, Issue 10, 2014, Pages 898-904

  Neupane, Sudan P ^a   Lien, Lars ^b,c   Martinez, Priscilla ^d   Aukrust, Pål ^a,e   Ueland, Thor ^a,e   Mollnes, Tom E ^a,e,f   Hestad, Knut ^b,g   Bramness, Jørgen G ^a,h  

^a UNIVERSITY OF OSLO   (Norway)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c INLAND NORWAY UNIVERSITY OF APPLIED SCIENCES   (Norway)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^h NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Alcohol; Comorbidity; Cytokines; Depression; Immune activation; Nepal

Indexed keywords

ALCOHOL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ALCOHOL DERIVATIVE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEPAL; PROTEIN BLOOD LEVEL; SMOKING; ADULT; ALCOHOLISM; BLOOD; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE;

ADULT; ALCOHOLISM; ALCOHOLS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPAL; PSYCHIATRIC STATUS RATING SCALES;

EID: 84908897577     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12303     Document Type: Article

References (37)

1. Mathers C, Fat DM, Boerma JT. The global burden of disease: 2004 update. Zeneva: World Health Organization, 2008.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC: American Psychiatric Association, 2013.
3. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457.
4. Liu Y, Ho RCM, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. J Affect Disord 2012;139:230-239.
5. Maes M, Scharpé S, Meltzer HY, et al. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response. Psychiatry Res 1994;54:143-160.
6. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
7. Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: Animal and human studies. Curr Pharm Des 2005;11:963-972.
8. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002;5:375-388.
9. Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005;67:187-194.
10. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011;24:519-525.
11. Sullivan LE, Fiellin DA, O'Connor PG. The prevalence and impact of alcohol problems in major depression: A systematic review. Am J Med 2005;118:330-341.
12. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:807-816.
13. Lynskey MT. The comorbidity of alcohol dependence and affective disorders: Treatment implications. Drug Alcohol Depend 1998;52:201-209.
14. Swendsen JD, Merikangas KR, Canino GJ, Kessler RC, Rubio-Stipec M, Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry 1998;39:176-184.
15. Neupane SP, Bramness JG. Prevalence and correlates of major depression among Nepalese patients in treatment for alcohol-use disorders. Drug Alcohol Rev 2013;32:170-177.
16. Goral J, Karavitis J, Kovacs EJ. Exposure-dependent effects of ethanol on the innate immune system. Alcohol 2008;42:237-247.
17. Crews FT, Bechara R, Brown LA, et al. Cytokines and alcohol. Alcohol Clin Exp Res 2006;30:720-730.
18. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009;33:220-232.
19. Achur RN, Freeman WM, Vrana KE. Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol 2010;5:83-91.
20. Schleifer SJ, Keller SE, Czaja S. Major depression and immunity in alcohol-dependent persons. Brain Behav Immun 2006;20:80-91.
21. Irwin M, Miller C. Decreased natural killer cell responses and altered interleukin-6 and interleukin-10 production in alcoholism: An interaction between alcohol dependence and African-American ethnicity. Alcohol Clin Exp Res 2000;24:560-569.
22. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: Relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 2010;65:429-433.
23. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test: Guidelines for use in primary care, 2nd edn. Zeneva: World Health Organization, 2001.
24. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 1974;19:1-15.
25. Carey KB, Carey MP, Chandra PS. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India. J Clin Psychiatry 2003;64:767-774.
26. Van Ommeren M, Sharma B, Thopa S, et al. Preparing instruments for transcultural research: Use of the translation monitoring form with Nepali-speaking Bhutanese refugees. Transcult Psychiatry 1999;36:285-301.
27. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 1994;28:57-84.
28. Kelley KW, Dantzer R. Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders. Brain Behav Immun 2011;25(suppl):13-20.
29. Halaris A. Inflammation, heart disease, and depression. Curr Psychiatry Rep 2013;15:1-9.
30. Gold SM, Irwin MR. Depression and immunity: Inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am 2009;29:309-320.
31. Jehn CF, Kuehnhardt D, Bartholomae A, et al. Biomarkers of depression in cancer patients. Cancer 2006;107:2723-2729.
32. Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007;25:225-230.
33. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin Exp Res 1998;22:1927-1942.
34. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: A prospective analysis. Biol Psychiatry 2012;71:15-21.
35. Badawy AA, Doughrty DM, Marsh-Richard DM, Steptoe A. Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects. Alcohol Alcohol 2009;44:267-271.
36. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2012;27:89-93.
37. Munzer A, Sack U, Mergl R, et al. Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins (Basel) 2013;5:2227-2240.